Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate
(26)
- Computing and Computational Sciences Directorate (38)
- Energy Science and Technology Directorate (223)
- Fusion and Fission Energy and Science Directorate (24)
- Information Technology Services Directorate (3)
- Isotope Science and Enrichment Directorate (7)
- National Security Sciences Directorate (20)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (135)
- User Facilities (27)
Researcher
- Andrzej Nycz
- Kuntal De
- Udaya C Kalluri
- Xiaohan Yang
- Alex Walters
- Biruk A Feyissa
- Brian Sanders
- Bruce Moyer
- Chris Masuo
- Clay Leach
- Debjani Pal
- Gerald Tuskan
- Ilenne Del Valle Kessra
- Isaiah Dishner
- Jeff Foster
- Jeffrey Einkauf
- Jennifer M Pyles
- Jerry Parks
- John F Cahill
- Josh Michener
- Justin Griswold
- Laetitia H Delmau
- Liangyu Qian
- Luke Sadergaski
- Mike Zach
- Padhraic L Mulligan
- Paul Abraham
- Sandra Davern
- Vilmos Kertesz
- Vincent Paquit
- Yang Liu

Enzymes for synthesis of sequenced oligoamide triads and tetrads that can be polymerized into sequenced copolyamides.
Contact
To learn more about this technology, email partnerships@ornl.gov or call 865-574-1051.

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

We present the design, assembly and demonstration of functionality for a new custom integrated robotics-based automated soil sampling technology as part of a larger vision for future edge computing- and AI- enabled bioenergy field monitoring and management technologies called

Detection of gene expression in plants is critical for understanding the molecular basis of plant physiology and plant responses to drought, stress, climate change, microbes, insects and other factors.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

Direct-acting antivirals are needed to combat coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.

Due to a genes unique nucleotide sequences acquired through horizontal gene transfer, the gene has a transcriptional repressor activity and innate enzymatic role.

There is a critical need for new antiviral drugs for treating infections of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2).

The invention provides on-line analysis of droplets for mass spectrometry.